2021
DOI: 10.7759/cureus.14522
|View full text |Cite
|
Sign up to set email alerts
|

Contrast Media-Induced Immune Hemolytic Anemia

Abstract: Drug-induced immune hemolytic anemia (DIIHA) is a rare type of immune-mediated hemolytic anemia, and mainly it is caused by antibiotics. There have been few case reports of contrast medium-induced immune hemolytic anemia. Here, we report a case of a 70-year-old woman who was admitted with communityacquired pneumonia. She had a CT abdomen and pelvis using iohexol (omnipaque), which resulted in severe hemolytic anemia and contributed to the patient's death. This case illustrates a very rare complication of IV co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 12 publications
0
4
0
Order By: Relevance
“…It is well known that the risk of an idiosyncratic allergic drug reaction varies with the treatment duration and most cases occur soon after a dose and are more common early after the first treatments [9][10][11]. Further, there are only very few cases in the available literature that show an association between an iodine-based contrast medium and the occurrence of agranulocytosis or hemolysis [12,13]. Moreover, we assume that both agranulocytosis and hemolysis are due to the same drug and not two different drugs independently of each other triggered rare complications at the same time.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is well known that the risk of an idiosyncratic allergic drug reaction varies with the treatment duration and most cases occur soon after a dose and are more common early after the first treatments [9][10][11]. Further, there are only very few cases in the available literature that show an association between an iodine-based contrast medium and the occurrence of agranulocytosis or hemolysis [12,13]. Moreover, we assume that both agranulocytosis and hemolysis are due to the same drug and not two different drugs independently of each other triggered rare complications at the same time.…”
Section: Discussionmentioning
confidence: 99%
“…It is well known that the risk of an idiosyncratic allergic drug reaction varies with the treatment duration and most cases occur soon after a dose and are more common early after the first treatments [ 9 11 ]. Further, there are only very few cases in the available literature that show an association between an iodine-based contrast medium and the occurrence of agranulocytosis or hemolysis [ 12 , 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, Omnipaque can induce changes in intravascular pressure and endothelial permeability. Recently, Omnipaque was reported to induce pituitary apoplexy[ 8 ], status epilepticus[ 9 ], immune hemolytic anemia[ 10 ], trigeminocardiac reflex[ 11 ] and encephalopathy[ 12 ] in some rare cases. In this case, Omnipaque-induced IC remains the most likely diagnosis based on the complete resolution of symptoms with antibiotic therapy and supportive management only.…”
Section: Discussionmentioning
confidence: 99%
“…The most common drugs associated with AIHA in the 1970s were methyldopa and penicillin, in the beginning of the 2000s were cefotetan, ceftriaxone [11,44] and piperacillin [49]. Current data indicates as drugs inducing AIHA antibiotics (cefotetan [50,51], ceftriaxone [52][53][54][55], penicillins [56], trimethoprim-sulfamethoxazole [57]), NSAIDs (diclofenac [47]), antineoplastic/chemotherapeutic drugs [11,12,46,58], cimetidine [59], and contrast media [60]. Our patient did not receive any of the medications known to be associated with drug-associated AIHA, and transfusions of PRBC were performed when anaemia became life-threatening.…”
Section: Discussionmentioning
confidence: 99%